;PMID: 8182306
;source_file_1791.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..58] = [t:0..58]
;1)sentence:[e:64..120] = [t:64..120]
;2)section:[e:124..145] = [t:124..145]
;3)section:[e:149..217] = [t:149..217]
;4)section:[e:221..304] = [t:221..304]
;5)section:[e:null] = [t:306..532]
;6)sentence:[e:308..532] = [t:null]
;7)sentence:[e:533..613] = [t:533..613]
;8)sentence:[e:614..737] = [t:614..737]
;9)sentence:[e:738..899] = [t:738..899]
;10)sentence:[e:900..1096] = [t:900..1096]
;11)sentence:[e:1098..1267] = [t:1098..1267]
;12)sentence:[e:1268..1434] = [t:1268..1434]
;13)sentence:[e:1435..1492] = [t:1435..1492]
;14)sentence:[e:1493..1560] = [t:1493..1560]
;15)sentence:[e:1562..1705] = [t:1562..1705]
;16)section:[e:1709..1753] = [t:1709..1753]
;Sentence Matching Errors
;ERROR_Tree section missing entity section[306..532]
;ERROR_Entity section missing treebank section[308..532]
;ERROR_Entity not in any tree[358..367] cyp450 "aromatase"
;ERROR_Entity not in any tree[404..410] substance "agents"
;ERROR_Entity not in any tree[414..423] cyp450 "aromatase"
;ERROR_Entity not in any tree[441..468] cyp450 "aromatase cytochrome  P-450"
;ERROR_Entity not in any tree[470..479] cyp450 "P-450arom"

;section 0 Span:0..58
;Nippon Sanka Fujinka Gakkai Zasshi. 1994 May;46(5):449-56.
(SEC
  (FRAG (NNP:[0..6] Nippon) (NNP:[7..12] Sanka) (NNP:[13..20] Fujinka)
        (NNP:[21..27] Gakkai) (NNP:[28..34] Zasshi) (.:[34..35] .)
        (CD:[36..40] 1994) (NNP:[41..44] May) (CD:[44..47] ;46)
        (-LRB-:[47..48] -LRB-) (CD:[48..49] 5) (-RRB-:[49..50] -RRB-)
        (::[50..51] :) (CD:[51..55] 449-) (CD:[55..57] 56) (.:[57..58] .)))

;sentence 1 Span:64..120
;[Regulation of aromatase in human choriocarcinoma cells]
;[79..88]:cyp450:"aromatase"
(SENT
  (NP-HLN (-LRB-:[64..65] -LSB-)
    (NP (NN:[65..75] Regulation))
    (PP (IN:[76..78] of)
      (NP (NN:[79..88] aromatase)))
    (PP-LOC (IN:[89..91] in)
      (NP (JJ:[92..97] human) (NN:[98..113] choriocarcinoma)
          (NNS:[114..119] cells)))
    (-RRB-:[119..120] -RSB-)))

;section 2 Span:124..145
;[Article in Japanese]
(SEC
  (FRAG (-LRB-:[124..125] -LSB-) (NN:[125..132] Article) (IN:[133..135] in)
        (JJ:[136..144] Japanese) (NNS:[144..145] -RSB-)))

;section 3 Span:149..217
;Kanno H, Kitawaki J, Maeda K, Kim T, Noguchi T, Yamamoto T, Okada H.
(SEC
  (FRAG (NNP:[149..154] Kanno) (NNP:[155..157] H,) (NNP:[158..166] Kitawaki)
        (NNP:[167..169] J,) (NNP:[170..175] Maeda) (NNP:[176..178] K,)
        (NNP:[179..182] Kim) (NNP:[183..184] T) (,:[184..185] ,)
        (NNP:[186..193] Noguchi) (NNP:[194..195] T) (,:[195..196] ,)
        (NNP:[197..205] Yamamoto) (NNP:[206..207] T) (,:[207..208] ,)
        (NNP:[209..214] Okada) (NNP:[215..217] H.)))

;section 4 Span:221..304
;Department of Obstetrics and Gynecology, Kyoto Prefectural University of 
;Medicine.
(SEC
  (FRAG (NNP:[221..231] Department) (IN:[232..234] of)
        (NNP:[235..245] Obstetrics) (CC:[246..249] and)
        (NNP:[250..260] Gynecology) (,:[260..261] ,) (NNP:[262..267] Kyoto)
        (NNP:[268..279] Prefectural) (NNP:[280..290] University)
        (IN:[291..293] of) (NNP:[295..303] Medicine) (.:[303..304] .)))

;section 5 Span:306..532
;  To examine the mechanism regulating trophoblastic aromatase, we studied the
; effects of various agents on aromatase activity and the aromatase cytochrome
; P-450 (P-450arom) concentration in human choriocarcinoma JEG-3 cells.
(SEC
  (S
    (S-PRP
      (NP-SBJ (-NONE-:[306..306] *))
      (VP (TO:[308..310] To)
        (VP (VB:[311..318] examine)
          (NP
            (NP (DT:[319..322] the) (NN:[323..332] mechanism))
            (VP (VBG:[333..343] regulating)
              (NP (JJ:[344..357] trophoblastic) (NN:[358..367] aromatase)))))))
    (,:[367..368] ,)
    (NP-SBJ (PRP:[369..371] we))
    (VP (VBD:[372..379] studied)
      (NP
        (NP (DT:[380..383] the) (NNS:[385..392] effects))
        (PP (IN:[393..395] of)
          (NP (JJ:[396..403] various) (NNS:[404..410] agents)))
        (PP (IN:[411..413] on)
          (NP
            (NP
              (NP (NN:[414..423] aromatase) (NN:[424..432] activity))
              (CC:[433..436] and)
              (NP (DT:[437..440] the)
                (NML
                  (NML (NN:[441..450] aromatase) (NN:[451..461] cytochrome)
                       (NN:[463..468] P-450))
                  (NML (-LRB-:[469..470] -LRB-) (NN:[470..479] P-450arom)
                       (-RRB-:[479..480] -RRB-)))
                (NN:[481..494] concentration)))
            (PP-LOC (IN:[495..497] in)
              (NP (JJ:[498..503] human) (NN:[504..519] choriocarcinoma)
                  (NN:[520..525] JEG-3) (NNS:[526..531] cells)))))))
    (.:[531..532] .)))

;sentence 6 Span:533..613
;Aromatase  activity was assessed by radioassay with [1 beta-3H]
;androstenedione.
;[533..542]:cyp450:"Aromatase"
;[585..612]:substance:"[1 beta-3H] androstenedione"
(SENT
  (S
    (NP-SBJ-1 (NN:[533..542] Aromatase) (NN:[544..552] activity))
    (VP (VBD:[553..556] was)
      (VP (VBN:[557..565] assessed)
        (NP-1 (-NONE-:[565..565] *))
        (PP-MNR (IN:[566..568] by)
          (NP
            (NP (NN:[569..579] radioassay))
            (PP (IN:[580..584] with)
              (NP
                (NML (-LRB-:[585..586] -LSB-) (CD:[586..587] 1)
                     (NN:[588..595] beta-3H) (-RRB-:[595..596] -RSB-))
                (NN:[597..612] androstenedione)))))))
    (.:[612..613] .)))

;sentence 7 Span:614..737
;The  P-450arom concentration was determined by an enzyme-linked immunosorbent
;assay  with specific antibodies to P-450arom.
;[619..628]:cyp450:"P-450arom"
;[664..670]:substance:"enzyme"
;[713..723]:substance:"antibodies"
;[727..736]:cyp450:"P-450arom"
(SENT
  (S
    (NP-SBJ-1 (DT:[614..617] The) (NN:[619..628] P-450arom)
              (NN:[629..642] concentration))
    (VP (VBD:[643..646] was)
      (VP (VBN:[647..657] determined)
        (NP-1 (-NONE-:[657..657] *))
        (PP (IN:[658..660] by)
          (NP-LGS
            (NP (DT:[661..663] an)
              (ADJP (NN:[664..670] enzyme) (HYPH:[670..671] -)
                    (VBN:[671..677] linked))
              (NN:[678..691] immunosorbent) (NN:[692..697] assay))
            (PP (IN:[699..703] with)
              (NP
                (NP (JJ:[704..712] specific) (NNS:[713..723] antibodies))
                (PP (TO:[724..726] to)
                  (NP (NN:[727..736] P-450arom)))))))))
    (.:[736..737] .)))

;sentence 8 Span:738..899
;Human chorionic gonadotropin (hCG)  stimulated aromatase activity and
;increased the P-450arom concentration in a  concentration-dependent (0.1-100
;IU/ml) manner.
;[738..766]:substance:"Human chorionic gonadotropin"
;[768..771]:substance:"hCG"
;[785..794]:cyp450:"aromatase"
;[822..831]:cyp450:"P-450arom"
;[877..884]:quantitative-value:"0.1-100"
;[885..890]:quantitative-units:"IU/ml"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[738..743] Human) (JJ:[744..753] chorionic)
          (NN:[754..766] gonadotropin))
      (NP (-LRB-:[767..768] -LRB-) (NN:[768..771] hCG) (-RRB-:[771..772] -RRB-)))
    (VP
      (VP (VBD:[774..784] stimulated)
        (NP (NN:[785..794] aromatase) (NN:[795..803] activity)))
      (CC:[804..807] and)
      (VP (VBD:[808..817] increased)
        (NP (DT:[818..821] the) (NN:[822..831] P-450arom)
            (NN:[832..845] concentration))
        (PP (IN:[846..848] in)
          (NP (DT:[849..850] a)
            (ADJP (NN:[852..865] concentration) (HYPH:[865..866] -)
                  (JJ:[866..875] dependent))
            (PRN (-LRB-:[876..877] -LRB-)
              (NP
                (NP
                  (QP (CD:[877..880] 0.1) (HYPH:[880..881] -)
                      (CD:[881..884] 100))
                  (NN:[885..887] IU))
                (PP (SYM:[887..888] /)
                  (NP (NN:[888..890] ml))))
              (-RRB-:[890..891] -RRB-))
            (NN:[892..898] manner)))))
    (.:[898..899] .)))

;sentence 9 Span:900..1096
;Cholera toxin (CT), an adenylate  cyclase activator, stimulated aromatase
;activity and the P-450arom concentration  in a concentration-dependent
;(0.1-10ng/ml) and a time-dependent (12-72h) manner.
;[900..913]:substance:"Cholera toxin"
;[915..917]:substance:"CT"
;[923..951]:substance:"adenylate  cyclase activator"
;[964..973]:cyp450:"aromatase"
;[991..1000]:cyp450:"P-450arom"
;[1046..1052]:quantitative-value:"0.1-10"
;[1052..1057]:quantitative-units:"ng/ml"
;[1081..1086]:quantitative-value:"12-72"
;[1086..1087]:quantitative-units:"h"
(SENT
  (S
    (NP-SBJ
      (NP
        (NP (NN:[900..907] Cholera) (NN:[908..913] toxin))
        (NP (-LRB-:[914..915] -LRB-) (NN:[915..917] CT) (-RRB-:[917..918] -RRB-)))
      (,:[918..919] ,)
      (NP (DT:[920..922] an)
        
        (NML (NN:[923..932] adenylate) (NN:[934..941] cyclase))
        (NN:[942..951] activator)))
    (,:[951..952] ,)
    (VP (VBD:[953..963] stimulated)
      (NP
        (NP (NN:[964..973] aromatase) (NN:[974..982] activity))
        (CC:[983..986] and)
        (NP (DT:[987..990] the) (NN:[991..1000] P-450arom)
            (NN:[1001..1014] concentration)))
      (PP (IN:[1016..1018] in)
        (NP
          (NP (DT:[1019..1020] a)
            (ADJP (NN:[1021..1034] concentration) (HYPH:[1034..1035] -)
                  (JJ:[1035..1044] dependent))
            (PRN (-LRB-:[1045..1046] -LRB-)
              (NP
                (NP
                  (QP (CD:[1046..1049] 0.1) (HYPH:[1049..1050] -)
                      (CD:[1050..1052] 10))
                  (NN:[1052..1054] ng))
                (PP (SYM:[1054..1055] /)
                  (NP (NN:[1055..1057] ml))))
              (-RRB-:[1057..1058] -RRB-))
            (NML-1 (-NONE-:[1058..1058] *P*)))
          (CC:[1059..1062] and)
          (NP (DT:[1063..1064] a)
            (ADJP (NN:[1065..1069] time) (HYPH:[1069..1070] -)
                  (JJ:[1070..1079] dependent))
            (PRN (-LRB-:[1080..1081] -LRB-)
              (NP
                (QP (CD:[1081..1083] 12) (HYPH:[1083..1084] -)
                    (CD:[1084..1086] 72))
                (NN:[1086..1087] h))
              (-RRB-:[1087..1088] -RRB-))
            (NML-1 (NN:[1089..1095] manner))))))
    (.:[1095..1096] .)))

;sentence 10 Span:1098..1267
;12-O-tetradecanoyl phorbol 13-acetate (TPA) (0.1-100ng/ml), a protein-kinase
;C  activator, also stimulated aromatase activity and increased the P-450arom 
;concentration.
;[1098..1135]:substance:"12-O-tetradecanoyl phorbol 13-acetate"
;[1137..1140]:substance:"TPA"
;[1143..1150]:quantitative-value:"0.1-100"
;[1150..1155]:quantitative-units:"ng/ml"
;[1160..1176]:substance:"protein-kinase C"
;[1178..1187]:substance:"activator"
;[1205..1214]:cyp450:"aromatase"
;[1242..1251]:cyp450:"P-450arom"
(SENT
  (S
    (NP-SBJ
      (NP
        (NP (NN:[1098..1116] 12-O-tetradecanoyl) (NN:[1117..1124] phorbol)
            (NN:[1125..1135] 13-acetate))
        (NP (-LRB-:[1136..1137] -LRB-) (NN:[1137..1140] TPA)
            (-RRB-:[1140..1141] -RRB-))
        (PRN (-LRB-:[1142..1143] -LRB-)
          (NP
            (NP
              (QP (CD:[1143..1146] 0.1) (HYPH:[1146..1147] -)
                  (CD:[1147..1150] 100))
              (NN:[1150..1152] ng))
            (PP (SYM:[1152..1153] /)
              (NP (NN:[1153..1155] ml))))
          (-RRB-:[1155..1156] -RRB-)))
      (,:[1156..1157] ,)
      (NP (DT:[1158..1159] a)
        (NML (NN:[1160..1167] protein) (HYPH:[1167..1168] -)
             (NN:[1168..1174] kinase) (NN:[1175..1176] C))
        (NN:[1178..1187] activator)))
    (,:[1187..1188] ,)
    (ADVP (RB:[1189..1193] also))
    (VP
      (VP (VBD:[1194..1204] stimulated)
        (NP (NN:[1205..1214] aromatase) (NN:[1215..1223] activity)))
      (CC:[1224..1227] and)
      (VP (VBD:[1228..1237] increased)
        (NP (DT:[1238..1241] the) (NN:[1242..1251] P-450arom)
            (NN:[1253..1266] concentration))))
    (.:[1266..1267] .)))

;sentence 11 Span:1268..1434
;On the other hand, Ca2+ ionophore A23187, an agent increasing  intracellular
;Ca2+ accumulation, inhibited aromatase activity and reduced the  P-450arom
;concentration.
;[1287..1301]:substance:"Ca2+ ionophore"
;[1302..1308]:substance:"A23187"
;[1313..1318]:substance:"agent"
;[1345..1349]:substance:"Ca2+"
;[1374..1383]:cyp450:"aromatase"
;[1410..1419]:cyp450:"P-450arom"
(SENT
  (S
    (PP (IN:[1268..1270] On)
      (NP (DT:[1271..1274] the) (JJ:[1275..1280] other) (NN:[1281..1285] hand)))
    (,:[1285..1286] ,)
    (NP-SBJ
      (NP
        
        (NML (NN:[1287..1290] Ca2) (SYM:[1290..1291] +))
        (NN:[1292..1301] ionophore)
        (NN:[1302..1308] A23187))
      (,:[1308..1309] ,)
      (NP
        (NP (DT:[1310..1312] an) (NN:[1313..1318] agent))
        (VP (VBG:[1319..1329] increasing)
          (NP (JJ:[1331..1344] intracellular)
            (NML (NN:[1345..1348] Ca2) (SYM:[1348..1349] +))
            (NN:[1350..1362] accumulation)))))
    (,:[1362..1363] ,)
    (VP
      (VP (VBD:[1364..1373] inhibited)
        (NP (NN:[1374..1383] aromatase) (NN:[1384..1392] activity)))
      (CC:[1393..1396] and)
      (VP (VBD:[1397..1404] reduced)
        (NP (DT:[1405..1408] the) (NN:[1410..1419] P-450arom)
            (NN:[1420..1433] concentration))))
    (.:[1433..1434] .)))

;sentence 12 Span:1435..1492
;The effects of CT, TPA and Ca2+ ionophore were  additive.
;[1450..1452]:substance:"CT"
;[1454..1457]:substance:"TPA"
;[1462..1476]:substance:"Ca2+ ionophore"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1435..1438] The) (NNS:[1439..1446] effects))
      (PP (IN:[1447..1449] of)
        (NP
          (NP (NN:[1450..1452] CT))
          (,:[1452..1453] ,)
          (NP (NN:[1454..1457] TPA))
          (CC:[1458..1461] and)
          (NP
            (NML (NN:[1462..1465] Ca2) (SYM:[1465..1466] +))
            (NN:[1467..1476] ionophore)))))
    (VP (VBD:[1477..1481] were)
      (ADJP-PRD (JJ:[1483..1491] additive)))
    (.:[1491..1492] .)))

;sentence 13 Span:1493..1560
;Aromatase activity was correlated with the P-450arom concentration.
;[1493..1502]:cyp450:"Aromatase"
;[1536..1545]:cyp450:"P-450arom"
(SENT
  (S
    (NP-SBJ-1 (NN:[1493..1502] Aromatase) (NN:[1503..1511] activity))
    (VP (VBD:[1512..1515] was)
      (VP (VBN:[1516..1526] correlated)
        (NP-1 (-NONE-:[1526..1526] *))
        (PP-CLR (IN:[1527..1531] with)
          (NP (DT:[1532..1535] the) (NN:[1536..1545] P-450arom)
              (NN:[1546..1559] concentration)))))
    (.:[1559..1560] .)))

;sentence 14 Span:1562..1705
;These results suggest that in JEG-3 cells the signal transduction system 
;modulates aromatase activity by changing the P-450arom concentration.
;[1646..1655]:cyp450:"aromatase"
;[1681..1690]:cyp450:"P-450arom"
(SENT
  (S
    (NP-SBJ (DT:[1562..1567] These) (NNS:[1568..1575] results))
    (VP (VBP:[1576..1583] suggest)
      (SBAR (IN:[1584..1588] that)
        (S
          (PP-LOC (IN:[1589..1591] in)
            (NP (NN:[1592..1597] JEG-3) (NNS:[1598..1603] cells)))
          (NP-SBJ (DT:[1604..1607] the) (NN:[1608..1614] signal)
                  (NN:[1615..1627] transduction) (NN:[1628..1634] system))
          (VP (VBZ:[1636..1645] modulates)
            (NP (NN:[1646..1655] aromatase) (NN:[1656..1664] activity))
            (PP-MNR (IN:[1665..1667] by)
              (S-NOM
                (NP-SBJ (-NONE-:[1667..1667] *))
                (VP (VBG:[1668..1676] changing)
                  (NP (DT:[1677..1680] the) (NN:[1681..1690] P-450arom)
                      (NN:[1691..1704] concentration)))))))))
    (.:[1704..1705] .)))

;section 15 Span:1709..1753
;PMID: 8182306 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1709..1713] PMID) (::[1713..1714] :) (CD:[1715..1722] 8182306)
        (NN:[1723..1724] -LSB-) (NNP:[1724..1730] PubMed) (::[1731..1732] -)
        (NN:[1733..1740] indexed) (IN:[1741..1744] for)
        (NNP:[1745..1753] MEDLINE-RSB-)))
